Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden; Central Health Directorate/Classification Area, Friuli Venezia Giulia Region, Italian Collaborating Centre for the WHO Family of International Classifications, Udine, Italy.
Epidemiological Service, Regional Health Directorate, Friuli Venezia Giulia Region, Udine, Italy.
J Psychosom Res. 2015 Nov;79(5):372-7. doi: 10.1016/j.jpsychores.2015.09.007. Epub 2015 Sep 25.
Many somatic disorders are complicated by depression and increase the risk of suicide. Little is known about whether antidepressants might reduce the suicidal risk in patients with somatic disorders.
Data on diagnoses and antidepressant prescriptions were derived from the Social and Health Information System of the Friuli Venezia Giulia Region. Cases were all suicides that occurred in the region during the years 2003-2013 and were sex- and age-matched to controls from the general population. Conditional logistic regression analysis was used to assess the association between suicide and somatic disorders.
The suicide rate in Friuli Venezia Giulia decreased from 11.3 to 10.7 per 100,000 inhabitants during the years 2003-2013, however patients with somatic disorder had a three times increased risk of suicide. Elderly somatic patients' suicide risk was twice as high as younger patients. The risk increased from 2.6 to 9.8 times as the number of comorbid disorders increased from 1 to 4 and over. Although no significant risk of suicide in patients with somatic disorders was found when patients were adherent to antidepressants, only 11.5% of the suicides was adherent in the year prior to death.
Medical illnesses and underlying depressive symptoms may have a synergy effect on the risk of suicide, particularly in older patients and in patients with multiple morbidities. Since medically ill subjects adherent to antidepressants did not show a significant risk of suicide, early identification and adequate treatment of depression in somatic patients should be considered in order to prevent suicide.
许多躯体疾病都伴有抑郁,并增加自杀的风险。对于抗抑郁药是否可以降低躯体疾病患者的自杀风险,知之甚少。
诊断和抗抑郁药物处方的数据来自弗留利-威尼斯朱利亚地区的社会和健康信息系统。病例均为 2003-2013 年期间该地区发生的自杀事件,并与普通人群中的对照进行了性别和年龄匹配。采用条件逻辑回归分析评估自杀与躯体疾病之间的关联。
2003-2013 年期间,弗留利-威尼斯朱利亚地区的自杀率从每 10 万人 11.3 例降至 10.7 例,但躯体疾病患者的自杀风险增加了三倍。老年躯体疾病患者的自杀风险是年轻患者的两倍。随着共病数量从 1 种增加到 4 种及以上,自杀风险从 2.6 倍增加到 9.8 倍。尽管在躯体疾病患者中,当患者遵医嘱使用抗抑郁药时,并未发现自杀的显著风险,但在死亡前一年,仅有 11.5%的自杀患者遵医嘱服药。
医学疾病和潜在的抑郁症状可能对自杀风险具有协同作用,特别是在老年患者和患有多种疾病的患者中。由于遵医嘱使用抗抑郁药的躯体疾病患者没有表现出明显的自杀风险,因此应考虑早期识别和充分治疗躯体疾病患者的抑郁,以预防自杀。